Table 1 Characteristics of the study cohort at baseline
From: Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
Total (n = 66) | |
|---|---|
Age in years, mean (SD) | 32 (7.8) |
Ethnicity, number (%) | |
White | 55 (83) |
Mixed | 5 (8) |
Asian | 1 (1) |
Black | 5 (8) |
Duration of IIH diagnosis, median (IQR) | 1.1 (0.5–2.6) |
Number on acetazolamide (%) | 19 (29) |
Number on topiramate (%) | 6 (9) |
Lumbar puncture opening pressure, cmCSF, mean (SD) | 35.5 (7.0) |
Weight, Kg (SD) | 118.5 (21.1) |
Body Mass Index (weight (kg)/ height (m2), mean (SD) | 43.9 (7.0) |
Smoking status - smoker | n = 27 |
Smoking intensity of 10 or more cigarettes per day, n (%) | 18 (67) |
Family history of primary headache disorder, % | 19 (7/37) |
Previous history of migraine, n (%) | 45 (68) |
Duration of migraine, n (%) | n = 45 |
Less than 1 year | 5 (11) |
1–5 years | 7 (16) |
5–10 years | 5 (11) |
10–20 years | 3 (7) |
More than 20 years | 1 (2) |
Since childhood (age < 18 years) | 24 (53) |
Headache preventative medication use, n (%) | n = 18 |
Beta-blocker | 1 (6) |
Tricyclic antidepressant | 7 (39) |
Anticonvulsant | 8 (44) |
Other | 2 (11) |